LIM Kinases in Osteosarcoma Development.

Abstract

Tumorigenesis is a long-term and multistage process that often leads to the formation of metastases. During this pathological course, two major events appear to be crucial: primary tumour growth and metastatic expansion. In this context, despite research and clinical advances during the past decades, bone cancers remain a leading cause of death worldwide among paediatric cancer patients. Osteosarcomas are the most common malignant bone tumours in children and adolescents. Notwithstanding advances in therapeutic treatments, many patients succumb to these diseases. In particular, less than 30% of patients who demonstrate metastases at diagnosis or are poor responders to chemotherapy survive 5 years after initial diagnosis. LIM kinases (LIMKs), comprising LIMK1 and LIMK2, are common downstream effectors of several signalization pathways, and function as a signalling node that controls cytoskeleton dynamics through the phosphorylation of the cofilin family proteins. In recent decades, several reports have indicated that the functions of LIMKs are mainly implicated in the regulation of actin microfilament and the control of microtubule dynamics. Previous studies have thus identified LIMKs as cancer-promoting regulators in multiple organ cancers, such as breast cancer or prostate cancer. This review updates the current understanding of LIMK involvement in osteosarcoma progression.

• Authors: Régis Brion, Laura Regnier, Mathilde Mullard, Jérome Amiaud, Françoise Rédini, Franck Verrecchia
• Journal: Cells (Cells) Vol. 10 Issue 12 (12 15 2021) ISSN: 2073-4409 [Electronic] Switzerland
• PMID: 34944050 (Publication Type: Journal Article, Review)

Chemical References

• Lim Kinases

Topics

• Animals
• Bone Neoplasms (enzymology)
• Bone Remodeling
• Humans
• Lim Kinases (metabolism)
• Models, Biological
• Osteogenesis
• Osteosarcoma (enzymology, pathology)